DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Ruilope LM, Dukat A, Böhm M et al.
Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.
Lancet 2010;
375: 1255-1266
We do not assume any responsibility for the contents of the web pages of other providers.